CHICAGO--(BUSINESS WIRE)--Feb. 21, 2006--As part of the recently signed technology transfer agreement, CytoCore, Inc. (OTCBB: MCDG), a bio-technology development company committed to bringing new cancer solutions to market, today announced that it has licensed a new cancer bio-marker from Dr. George Gorodeski, the inventor, and University Hospitals Cleveland.
